Search Ontology:
ChEBI

levofloxacin

Term ID
CHEBI:63598
Synonyms
  • (-)-ofloxacin
  • (3S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
  • (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
  • (S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
  • (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
  • (S)-ofloxacin
  • DR 3355
  • DR-3355
  • L-ofloxacin
  • levofloxacin
  • levofloxacine
  • levofloxacino
  • levofloxacinum
  • Ofloxacin S-(-)-form
  • S-(-)-ofloxacin
Definition
An optically active form of ofloxacin having (S)-configuration; an inhibitor of bacterial topoisomerase IV and DNA gyrase.
References
  • cas:100986-85-4
  • drugbank:DB01137
  • drugcentral:1569
  • hmdb:HMDB0001929
  • kegg.compound:C07660
  • kegg.drug:D08120
  • lincs.smallmolecule:LSM-5270
  • pdb-ccd:LFX
  • pubmed:10803495
  • pubmed:11141388
  • pubmed:11181130
  • pubmed:11249554
  • pubmed:11558453
  • pubmed:11898264
  • pubmed:11975700
  • pubmed:14581720
  • pubmed:15969945
  • pubmed:17549677
  • pubmed:19212411
  • pubmed:20596531
  • pubmed:2079448
  • pubmed:21075586
  • pubmed:21965436
  • pubmed:21974858
  • pubmed:22088660
  • pubmed:22221614
  • pubmed:23965305
  • pubmed:26792525
  • pubmed:27050128
  • pubmed:34323366
  • pubmed:34824229
  • pubmed:36076992
  • pubmed:36102678
  • pubmed:36119964
  • pubmed:36135690
  • pubmed:36314364
  • pubmed:36328279
  • pubmed:8656585
  • pubmed:8957581
  • pubmed:9068926
  • pubmed:9624783
  • reaxys:5385660
  • vsdb:1899
  • wikipedia.en:Levofloxacin
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from levofloxacin
Phenotype where environments contain levofloxacin
Phenotype modified by environments containing levofloxacin
Phenotype affecting levofloxacin
Human Disease Model